BRIEF published on 03/10/2025 at 15:34, 1 year 7 months ago Goldman Sachs reduces its stake in EUROAPI Euronext Paris Participation Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 02/14/2025 at 12:20, 1 year 8 months ago Goldman Sachs Crosses Threshold in EUROAPI Acquisition Goldman Sachs Crossing Thresholds Shares And Voting Rights EUROAPI
BRIEF published on 02/11/2025 at 14:00, 1 year 8 months ago Goldman Sachs reduces its stake in EUROAPI Stock Market Goldman Sachs Threshold Crossing Transfer Of Shares EUROAPI
BRIEF published on 01/31/2025 at 14:28, 1 year 8 months ago Threshold Crossings by The Goldman Sachs Group, Inc. at EUROAPI Actions Financial Market Goldman Sachs Crossing Thresholds EUROAPI
BRIEF published on 12/09/2024 at 20:22, 1 year 10 months ago EUROAPI Enters a New Chapter with Leadership Changes Pharmaceuticals 2024 Outlook Leadership Change EUROAPI FOCUS-27 Plan
PRESS RELEASE published on 12/09/2024 at 20:17, 1 year 10 months ago EUROAPI moves into a new chapter with new Governance and Leadership EUROAPI enters a new chapter with new Governance and Leadership as Emmanuel Blin becomes Independent Chair of the Board and David Seignolle appointed Chief Executive Officer, maintaining full-year 2024 guidance Governance Leadership EUROAPI Emmanuel Blin David Seignolle
BRIEF published on 10/16/2024 at 07:05, 2 years ago Appointment of Olivier Falut as Financial Director of EUROAPI Appointment Financial Director EUROAPI Olivier Falut FOCUS-27 Transformation
PRESS RELEASE published on 10/16/2024 at 07:00, 2 years ago Olivier Falut appointed EUROAPI’s Chief Financial Officer Olivier Falut appointed EUROAPI's Chief Financial Officer. He brings 30 years of financial management experience in the industrial sector. EUROAPI focuses on innovative active ingredient solutions for global health Chief Financial Officer Industrial Sector EUROAPI Active Ingredient Solutions Olivier Falut
BRIEF published on 10/10/2024 at 20:43, 2 years ago EUROAPI secures financing for its FOCUS-27 plan Funding Sanofi EUROAPI Hybrid Bond FOCUS-27 Plan
PRESS RELEASE published on 10/10/2024 at 20:38, 2 years ago EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution EUROAPI completes financing of FOCUS-27 plan, refinancing €451M Credit Facility & issuing €200M Hybrid Bond, enhancing collaboration with Sanofi Financing Partnership Sanofi EUROAPI FOCUS-27
Published on 10/23/2026 at 02:20, 9 hours 43 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 12 hours 33 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 13 hours 33 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 20 hours 3 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 21 hours 33 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 11:45, 18 minutes ago Original-Research: Grand City Properties SA (von First Berlin Equity Research GmbH): Kaufen
Published on 10/23/2026 at 11:30, 33 minutes ago Bulgarian Financial Supervision Commission completes preliminary review of the voluntary public takeover offer for Shelly Group SE
Published on 10/23/2026 at 11:30, 33 minutes ago Acceptance period of Sazerac’s voluntary public takeover offer for Berentzen-Gruppe Aktiengesellschaft commences
Published on 10/23/2026 at 11:00, 1 hour 3 minutes ago Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/22/2026 at 18:00, 18 hours 3 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 18 hours 3 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 18 hours 3 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 18 hours 16 minutes ago Aéroports de Paris SA - 2026 9-month revenue
